These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39385266)

  • 1. Preferences for pre-exposure prophylaxis delivery via online pharmacy among potential users in Kenya: a discrete choice experiment.
    Saldarriaga EM; Chen Y; Montaño MA; Thuo N; Kiptinness C; Terris-Prestholt F; Stergachis A; Mugambi ML; Ngure K; Ortblad KF; Sharma M
    J Int AIDS Soc; 2024 Oct; 27(10):e26356. PubMed ID: 39385266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: protocol for a discrete choice experiment.
    Chen Y; Saldarriaga EM; Montano MA; Ngure K; Thuo N; Kiptinness C; Rafferty M; Terris-Prestholt F; Stergachis A; Mugambi ML; Ortblad KF; Sharma M
    BMJ Open; 2023 Apr; 13(4):e069195. PubMed ID: 37012008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for a community pharmacy-based pre-exposure prophylaxis (PrEP) delivery program: A discrete choice experiment.
    Goswami S; Bentley JP; Kang M; Bhattacharya K; Barnard M
    J Am Pharm Assoc (2003); 2024; 64(4):102091. PubMed ID: 38604477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
    Mugambi ML; Odhiambo BO; Dollah A; Marwa MM; Nyakina J; Kinuthia J; Baeten JM; Weiner BJ; John-Stewart G; Barnabas RV; Hauber B
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Online HIV prophylaxis delivery: Protocol for the ePrEP Kenya pilot study.
    Kiptinness C; Naik P; Thuo N; Malen RC; Dettinger JC; Pintye J; Rafferty M; Jomo E; Nyamasyo N; Wood T; Isabelli P; Morris S; Hattery D; Stergachis A; Were D; Sharma M; Ngure K; Mugambi ML; Ortblad KF
    Front Public Health; 2023; 11():1054559. PubMed ID: 36908449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low selection of HIV PrEP refills at private pharmacies among clients who initiated PrEP at public clinics: findings from a mixed-methods study in Kenya.
    Ortblad KF; Kuo AP; Mogere P; Roche SD; Kiptinness C; Wairimu N; Gakuo S; Baeten JM; Ngure K
    BMC Health Serv Res; 2024 May; 24(1):618. PubMed ID: 38730398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM; Atujuna M; Browne EN; Ndwayana S; Hartmann M; Sindelo S; Ngcwayi N; Boeri M; Mansfield C; Bekker LG; Montgomery ET
    J Int AIDS Soc; 2020 Jun; 23(6):e25528. PubMed ID: 32544303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the performance of HIV self-testing at private pharmacies in Kenya: a cross-sectional study.
    Ortblad KF; Kwach B; Zhang S; Asewe M; Ongwen PA; Malen RC; Harkey K; Odoyo J; Gathii P; Rota G; Sharma M; Were DK; Ngure K; Omollo V; Bukusi EA
    J Int AIDS Soc; 2023 Oct; 26(10):e26177. PubMed ID: 37848405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stand-alone model for delivery of oral HIV pre-exposure prophylaxis in Kenya: a single-arm, prospective pilot evaluation.
    Ortblad KF; Mogere P; Omollo V; Kuo AP; Asewe M; Gakuo S; Roche S; Mugambi M; Mugambi ML; Stergachis A; Odoyo J; Bukusi EA; Ngure K; Baeten JM
    J Int AIDS Soc; 2023 Jun; 26(6):e26131. PubMed ID: 37306128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.
    Cole SW; Glick JL; Campoamor NB; Sanchez TH; Sarkar S; Vannappagari V; Rinehart A; Rawlings K; Sullivan PS; Bridges JFP
    BMJ Open; 2024 Apr; 14(4):e083837. PubMed ID: 38653510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a care pathway for pharmacy-based PrEP delivery in Kenya: results from a collaborative stakeholder consultation.
    Ortblad KF; Mogere P; Roche S; Kamolloh K; Odoyo J; Irungu E; Mugo NR; Pintye J; Baeten JM; Bukusi E; Ngure K;
    BMC Health Serv Res; 2020 Nov; 20(1):1034. PubMed ID: 33176785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for Delivery of HIV Prevention Services Among Healthcare Users in South Africa: A Discrete Choice Experiment.
    Martin CE; Blaauw D; Nongena P; Chidumwa G; Dada S; Jack S; Butler V; Mullick S
    AIDS Behav; 2024 Oct; ():. PubMed ID: 39349906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formalized peer referral to HIV pre-exposure prophylaxis supported with self-testing: a mixed-methods pilot study among young Kenyan women.
    McGowan M; Wairimu N; Reedy AM; Mogere P; Culquichicon C; Njeru I; Malen RC; Jahn A; Bärnighausen T; Roche SD; Ngure K; Ortblad KF
    Front Public Health; 2024; 12():1428609. PubMed ID: 39324163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK; Pintye J; Harrington E; Houck S; Kwena Z; Lenn M; Mogaka F; Momanyi V; Mugambi M; Nyerere B; Odoyo J; Omollo V; Ortblad KF; Rota G; Sharma M; Bukusi EA
    Trials; 2024 Jun; 25(1):394. PubMed ID: 38890744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
    Little KM; Hanif H; Anderson SM; Clark MR; Gustafson K; Doncel GF
    AIDS Behav; 2024 Mar; 28(3):936-950. PubMed ID: 37971614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived access to PrEP as a critical step in engagement: A qualitative analysis and discrete choice experiment among young men who have sex with men.
    Asiago-Reddy EA; McPeak J; Scarpa R; Braksmajer A; Ruszkowski N; McMahon J; London AS
    PLoS One; 2022; 17(1):e0258530. PubMed ID: 35081116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya.
    Wanga V; Omollo V; Bukusi EA; Odoyo JB; Morton JF; Kidoguchi L; Johnson R; Hughes JP; Celum C; Baeten JM
    J Int AIDS Soc; 2020 Aug; 23(8):e25561. PubMed ID: 32820597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Vera M; Bukusi E; Achieng P; Aketch H; Araka E; Baeten JM; Beima-Sofie K; John-Stewart G; Kohler PK; Mugambi ML; Nyerere B; Odoyo J; Omom C; Omondi C; Ortblad KF; Pintye J
    J Int Assoc Provid AIDS Care; 2023; 22():23259582231215882. PubMed ID: 37997351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.